YANG Qiang, WANG Xiang, MA Shenghui, LI Xin. Chemotherapy with oxaliplatin and tegafur gimeracil oteracil potassium capsule versus oxaliplatin-assisted xihuang capsules in the treatment of patients with advanced gastric cancer and its effects on T cell subsets,survival rate and adverse reactions[J]. Journal of Clinical Medicine in Practice, 2017, (17): 51-54. DOI: 10.7619/jcmp.201717015
Citation:
|
YANG Qiang, WANG Xiang, MA Shenghui, LI Xin. Chemotherapy with oxaliplatin and tegafur gimeracil oteracil potassium capsule versus oxaliplatin-assisted xihuang capsules in the treatment of patients with advanced gastric cancer and its effects on T cell subsets,survival rate and adverse reactions[J]. Journal of Clinical Medicine in Practice, 2017, (17): 51-54. DOI: 10.7619/jcmp.201717015
|
YANG Qiang, WANG Xiang, MA Shenghui, LI Xin. Chemotherapy with oxaliplatin and tegafur gimeracil oteracil potassium capsule versus oxaliplatin-assisted xihuang capsules in the treatment of patients with advanced gastric cancer and its effects on T cell subsets,survival rate and adverse reactions[J]. Journal of Clinical Medicine in Practice, 2017, (17): 51-54. DOI: 10.7619/jcmp.201717015
Citation:
|
YANG Qiang, WANG Xiang, MA Shenghui, LI Xin. Chemotherapy with oxaliplatin and tegafur gimeracil oteracil potassium capsule versus oxaliplatin-assisted xihuang capsules in the treatment of patients with advanced gastric cancer and its effects on T cell subsets,survival rate and adverse reactions[J]. Journal of Clinical Medicine in Practice, 2017, (17): 51-54. DOI: 10.7619/jcmp.201717015
|